SWTX
SpringWorks Therapeutics Inc. Common Stock
$0.000+0.000 (0.000%)
Real-time Price
Price Chart
No chart data available
Key Metrics
Market Metrics
Open
$0.000
High
$0.000
Low
$0.000
Volume
N/A
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.